Eagle Pharmaceuticals to Discuss Third Quarter 2015 Financial Results on November 11, 2015

Thursday, October 29, 2015 4:30 pm EDT

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle") (Nasdaq:EGRX) will release its 2015 third quarter financial results on Wednesday, November 11, 2015, before the market opens.

Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host a conference call to discuss the results as follows:

 
Date Wednesday, November 11, 2015
Time 8:30 a.m. EST
Toll free (U.S.) 877-876-9177
International 785-424-1666
Webcast (live and replay)

www.eagleus.com. under the “Investor Relations” section

 

A replay of the conference call will be available for one week after the call's completion by dialing 800-839-3735 (U.S.) or 402-220-2977 (International) and entering conference call ID EGRXQ315. The webcast will be archived for 30 days at the aforementioned URL.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

Contact:

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Business Wire InvestorHQsm